Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

312 Press Releases
DateTitleCompany
28 Nov 16 Sanofi: Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
22 Nov 16 Sanofi Receives FDA Approval of Soliqua™ 100/33 for the Treatment of Adults with Type 2 Diabetes Sanofi ,
Published by
PharmiWeb.com
22 Nov 16 Sanofi Receives FDA Approval of Soliqua(TM) 100/33, for the Treatment of Adults with Type 2 Diabetes Sanofi,
Published by
GlobeNewswire
17 Nov 16 Sanofi and Regeneron Announce Praluent® (alirocumab) Cardiovascular Outcomes Trial will Continue as Planned Following Interim Analysis Sanofi,
Published by
GlobeNewswire
16 Nov 16 Sanofi: Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16... Sanofi,
Published by
GlobeNewswire
11 Nov 16 Sanofi Receives CHMP Recommendation for Approval of SuliquaTM in the EU Sanofi,
Published by
GlobeNewswire
07 Nov 16 Sanofi : Disclosure of trading in own shares Sanofi,
Published by
GlobeNewswire
04 Nov 16 Sanofi Genzyme Begins Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease Sanofi Genzyme,
Published by
Business Wire
28 Oct 16 Sanofi : Sanofi and Regeneron Receive Complete Response Letter from FDA for Sarilumab, an Investigational Treatment for Rheumatoid Arthritis Sanofi,
Published by
GlobeNewswire
27 Oct 16 Sanofi Pasteur, Fiocruz, and WRAIR Agree to Collaborate on Zika Vaccine Research Sanofi,
Published by
GlobeNewswire
13 Oct 16 High-Dose Influenza Vaccine with Evidence of Superior Efficacy* in Older Adults: Now in Canada Sanofi Pasteur,
Published by
PR Newswire
06 Oct 16 BARDA Awards $37.6 million Contract to Sanofi to Supply Leukine® (sargramostim) for Potential Public Health Emergency Sanofi Genzyme,
Published by
Business Wire
30 Sep 16 Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer HealthCare Sanofi,
Published by
GlobeNewswire
27 Sep 16 BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika Sanofi ,
Published by
PharmiWeb.com
26 Sep 16 Sanofi : BARDA Grants $43.2 million USD to Sanofi Pasteur for Zika Sanofi,
Published by
GlobeNewswire
26 Sep 16 Sanofi and Regeneron Announce Dupilumab Biologics License Application Accepted for Priority Review by U.S. FDA Sanofi,
Published by
GlobeNewswire
22 Sep 16 Data on Treatment Effects with Lemtrada® (alemtuzumab) Over Six Years in People with Relapsing Remitting Multiple Sclerosis to be presented at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London Sanofi Genzyme
19 Sep 16 Sanofi Files Suit in U.S. to Defend Paten Rights on Lantus® and Lantus® Solostar® Sanofi,
Published by
GlobeNewswire
13 Sep 16 Sanofi and Verily Life Sciences Announce Launch of Onduo, a Joint Venture to Develop Comprehensive Diabetes Management Platform Sanofi,
Published by
PharmiWeb.com
13 Sep 16 Sanofi’s Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone Sanofi,
Published by
PharmiWeb.com
15 Sep 16 Toujeo® Demonstrates a More Stable Profile and Lower Within-day Variability Compared to Insulin Degludec Sanofi,
Published by
PR Newswire
15 Sep 16 Results from 1,000-Patient, Global Real-World Patient-Reported Outcomes Study of Sanofi Genzyme’s Aubagio® (teriflunomide) in Patients with Relapsing Multiple Sclerosis Demonstrate High Levels of Treatment Satisfaction Sanofi Genzyme,
Published by
Business Wire
27 Aug 16 New Brunswick includes LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients Sanofi Genzyme,
Published by
PharmiWeb.com
23 Aug 16 Sanofi : Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of th... Sanofi,
Published by
GlobeNewswire
13 Aug 16 Sanofi: Dengue Immunization Public Program in Paraná State of Brazil Set To Achieve WHO 2020 Ambition Sanofi,
Published by
GlobeNewswire
01 Sep 16 Alberta includes LEMTRADA® (alemtuzumab) on provincial drug program for eligible patients Sanofi Genzyme,
Published by
PR Newswire
16 Sep 16 Sanofi Presents New Data for an Investigational Fixed-Ratio Combination of Insulin Glargine and Lixisenatide at the European Association for the Study of Diabetes 52nd Annual Meeting Sanofi ,
Published by
PharmiWeb.com
01 Aug 16 Sanofi and Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab Sanofi ,
Published by
PharmiWeb.com
13 Sep 16 Sanofi's Fixed-Ratio Combination Helps More Patients Reach Mealtime Blood Sugar Target than Insulin Glargine Alone Sanofi,
Published by
GlobeNewswire
19 Aug 16 Sanofi Provides Update on New Drug Application for Investigational Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Sanofi,
Published by
GlobeNewswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.